SD Biosensor, Inc (KRX: 137310)
South Korea
· Delayed Price · Currency is KRW 10,640
-90 (-0.84%)
Dec 20, 2024, 3:30 PM KST
SD Biosensor Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 674,066 | 655,677 | 2,932,001 | 2,929,961 | 1,686,163 | 72,962 |
| Other Revenue | -0 | -0 | - | - | - | - |
| Revenue | 674,066 | 655,677 | 2,932,001 | 2,929,961 | 1,686,163 | 72,962 |
| Revenue Growth (YoY) | -2.80% | -77.64% | 0.07% | 73.76% | 2211.01% | - |
| Cost of Revenue | 352,293 | 533,227 | 1,541,891 | 1,336,785 | 829,530 | 52,386 |
| Gross Profit | 321,774 | 122,449 | 1,390,110 | 1,593,176 | 856,633 | 20,576 |
| Selling, General & Admin | 195,117 | 206,811 | 169,176 | 177,655 | 102,344 | 12,154 |
| Research & Development | 78,600 | 64,203 | 45,762 | 19,086 | 10,388 | 4,869 |
| Other Operating Expenses | 3,016 | 2,810 | 3,527 | 1,571 | 716.9 | 330.52 |
| Operating Expenses | 387,374 | 370,534 | 243,486 | 205,443 | 118,369 | 19,056 |
| Operating Income | -65,600 | -248,085 | 1,146,624 | 1,387,733 | 738,264 | 1,520 |
| Interest Expense | -66,159 | -49,228 | -994.06 | -488.66 | -433.63 | -251.49 |
| Interest & Investment Income | 20,773 | 23,487 | 26,486 | 6,702 | 489.67 | 90.1 |
| Currency Exchange Gain (Loss) | 677.04 | -22,710 | 92,362 | 65,296 | -26,100 | 840.92 |
| Other Non Operating Income (Expenses) | -1,488 | -44,224 | -12,500 | -3,359 | -487.1 | 212.73 |
| EBT Excluding Unusual Items | -111,797 | -340,759 | 1,251,979 | 1,455,883 | 711,734 | 2,412 |
| Gain (Loss) on Sale of Investments | -2,019 | 3,059 | 547.95 | 12,282 | 6,084 | -153.45 |
| Gain (Loss) on Sale of Assets | 4,431 | -1,045 | -1,804 | -1,373 | -580.55 | -56.06 |
| Asset Writedown | -99,869 | -99,869 | -8,634 | -2,283 | - | - |
| Pretax Income | -209,254 | -438,614 | 1,242,088 | 1,464,509 | 717,237 | 2,202 |
| Income Tax Expense | -146,671 | 29,290 | 333,300 | 376,385 | 95,623 | -928.64 |
| Earnings From Continuing Operations | -62,583 | -467,904 | 908,789 | 1,088,124 | 621,614 | 3,131 |
| Minority Interest in Earnings | -634.79 | 192.56 | 2,574 | 346.26 | -5,978 | 22.08 |
| Net Income | -63,218 | -467,712 | 911,362 | 1,088,471 | 615,636 | 3,153 |
| Net Income to Common | -63,218 | -467,712 | 911,362 | 1,088,471 | 615,636 | 3,153 |
| Net Income Growth | - | - | -16.27% | 76.80% | 19424.28% | - |
| Shares Outstanding (Basic) | 122 | 111 | 101 | 98 | 93 | 82 |
| Shares Outstanding (Diluted) | 122 | 111 | 101 | 98 | 94 | 82 |
| Shares Change (YoY) | 15.75% | 9.44% | 3.87% | 4.28% | 13.56% | - |
| EPS (Basic) | -516.68 | -4218.95 | 8996.76 | 11161.38 | 6597.15 | 38.29 |
| EPS (Diluted) | -516.68 | -4219.00 | 8996.76 | 11161.00 | 6583.00 | 38.00 |
| EPS Growth | - | - | -19.39% | 69.54% | 17223.68% | - |
| Free Cash Flow | 75,739 | -384,884 | 587,008 | 1,044,892 | 440,478 | -9,076 |
| Free Cash Flow Per Share | 619.00 | -3471.82 | 5794.81 | 10714.52 | 4710.19 | -110.21 |
| Gross Margin | 47.74% | 18.68% | 47.41% | 54.38% | 50.80% | 28.20% |
| Operating Margin | -9.73% | -37.84% | 39.11% | 47.36% | 43.78% | 2.08% |
| Profit Margin | -9.38% | -71.33% | 31.08% | 37.15% | 36.51% | 4.32% |
| Free Cash Flow Margin | 11.24% | -58.70% | 20.02% | 35.66% | 26.12% | -12.44% |
| EBITDA | 83,182 | -110,543 | 1,187,444 | 1,406,848 | 746,239 | 5,850 |
| EBITDA Margin | 12.34% | -16.86% | 40.50% | 48.02% | 44.26% | 8.02% |
| D&A For EBITDA | 148,782 | 137,541 | 40,820 | 19,115 | 7,974 | 4,331 |
| EBIT | -65,600 | -248,085 | 1,146,624 | 1,387,733 | 738,264 | 1,520 |
| EBIT Margin | -9.73% | -37.84% | 39.11% | 47.36% | 43.78% | 2.08% |
| Effective Tax Rate | - | - | 26.83% | 25.70% | 13.33% | - |
| Advertising Expenses | - | 5,988 | 14,830 | 10,329 | 2,050 | 863.32 |
Source: S&P Capital IQ. Standard template. Financial Sources.